Hbm Holdings Ltd
HKEX:2142
Hbm Holdings Ltd
Income from Continuing Operations
Hbm Holdings Ltd
Income from Continuing Operations Peer Comparison
Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors
Company | Income from Continuing Operations | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
H
|
Hbm Holdings Ltd
HKEX:2142
|
Income from Continuing Operations
$22.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
C
|
China Regenerative Medicine International Ltd
HKEX:8158
|
Income from Continuing Operations
-HK$107.7m
|
CAGR 3-Years
11%
|
CAGR 5-Years
39%
|
CAGR 10-Years
N/A
|
Uni-Bio Science Group Ltd
HKEX:690
|
Income from Continuing Operations
HK$70.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
CK Life Sciences Intl (Holdings) Inc
HKEX:775
|
Income from Continuing Operations
HK$17.3m
|
CAGR 3-Years
-48%
|
CAGR 5-Years
-44%
|
CAGR 10-Years
N/A
|
|
Essex Bio-Technology Ltd
HKEX:1061
|
Income from Continuing Operations
HK$275.3m
|
CAGR 3-Years
8%
|
CAGR 5-Years
4%
|
CAGR 10-Years
N/A
|
See Also
What is Hbm Holdings Ltd's Income from Continuing Operations?
Income from Continuing Operations
22.8m
USD
Based on the financial report for Dec 31, 2023, Hbm Holdings Ltd's Income from Continuing Operations amounts to 22.8m USD.